| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1From the Department of Ophthalmology, University of Erlangen-Nürnberg, Erlangen, Germany; and the 2University Department of Ophthalmology, AHEPA Hospital, Thessaloniki, Greece.
PURPOSE. To determine the presence, activity, and quantitative differences of matrix metalloproteinases (MMPs) and their endogenous inhibitors (TIMPs) in aqueous humor and serum samples of patients with pseudoexfoliation (PEX) syndrome, PEX glaucoma (PEXG), primary open-angle glaucoma (POAG), and cataract.
METHODS. Aqueous humor and serum samples were collected from 100 patients with PEX syndrome, PEX glaucoma (PEXG), POAG, and cataract, respectively. Levels of MMP-1, -2, -3, -7, -9, and -12 and TIMP-1 and -2 were determined by zymography, Western blot analysis, and specific immunoassays. Activity assay kits were used to quantitate levels of endogenously activated MMP-2 and -9.
RESULTS. MMP-2, -3, -7, -9, and -12 and TIMP-1 and -2 were identified in human aqueous humor samples from all groups of patients with a six to sevenfold molar excess of TIMPs over MMPs. Whereas serum samples showed no significant differences, total MMP-2 and -3 and TIMP-1 and -2 were detected at significantly higher concentrations in aqueous samples from PEX eyes with and without glaucoma compared with cataractous eyes. MMP-2 and -3 and TIMP-1 were also detected in higher, but not significantly different, amounts in aqueous samples of POAG eyes. However, levels of endogenously activated MMP-2 were significantly decreased in both PEX and POAG samples. The ratio of MMP-2 to its principal inhibitor TIMP-2 was balanced in cataract samples, but was decreased in samples from patients with PEXG, resulting in an excess of TIMP-2 over MMP-2.
CONCLUSIONS. The findings suggest that complex changes in the local MMP-TIMP balance and reduced MMP activity in aqueous humor may promote the abnormal matrix accumulation characteristic of PEX syndrome and may be causally involved in the pathogenesis of both PEX glaucoma and POAG.
This article has been cited by other articles:
|
|
 |
|
  Y. Liu, S. Schmidt, X. Qin, J. Gibson, K. Hutchins, C. Santiago-Turla, J. L. Wiggs, D. L. Budenz, S. Akafo, P. Challa, et al. Lack of Association between LOXL1 Variants and Primary Open-Angle Glaucoma in Three Different Populations Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3465 - 3468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. V. Johnson, S. Fan, C. B. Camras, and C. B. Toris Aqueous Humor Dynamics in Exfoliation Syndrome Arch Ophthalmol, July 1, 2008; 126(7): 914 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lemmela, E. Forsman, P. Sistonen, A. Eriksson, H. Forsius, and I. Jarvela Genome-Wide Scan of Exfoliation Syndrome Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4136 - 4142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Hodgkinson, G. Duncan, L. Wang, C. J. Pennington, D. R. Edwards, and I. M. Wormstone MMP and TIMP Expression in Quiescent, Dividing, and Differentiating Human Lens Cells Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4192 - 4199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Ovodenko, A. Rostagno, T. A. Neubert, V. Shetty, S. Thomas, A. Yang, J. Liebmann, J. Ghiso, and R. Ritch Proteomic Analysis of Exfoliation Deposits Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1447 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zenkel, F. E. Kruse, A. G. Junemann, G. O. H. Naumann, and U. Schlotzer-Schrehardt Clusterin Deficiency in Eyes with Pseudoexfoliation Syndrome May Be Implicated in the Aggregation and Deposition of Pseudoexfoliative Material Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1982 - 1990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ito, H. Ohguro, K. Mamiya, I. Ohguro, and M. Nakazawa Effects of Antiglaucoma Drops on MMP and TIMP Balance in Conjunctival and Subconjunctival Tissue. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 823 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rosch, R. Ramer, K. Brune, and B. Hinz R(+)-Methanandamide and Other Cannabinoids Induce the Expression of Cyclooxygenase-2 and Matrix Metalloproteinases in Human Nonpigmented Ciliary Epithelial Cells J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1219 - 1228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zenkel, E. Poschl, K. von der Mark, C. Hofmann-Rummelt, G. O. H. Naumann, F. E. Kruse, and U. Schlotzer-Schrehardt Differential Gene Expression in Pseudoexfoliation Syndrome Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3742 - 3752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S L Ho, G F Dogar, J Wang, J Crean, Q D Wu, N Oliver, S Weitz, A Murray, P E Cleary, and C O'Brien Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome Br. J. Ophthalmol., February 1, 2005; 89(2): 169 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Eibl, B. Banas, D. Kook, A. V. Ohlmann, S. Priglinger, A. Kampik, and U. C. Welge-Luessen Alkylphosphocholines: A New Therapeutic Option in Glaucoma Filtration Surgery Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2619 - 2624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G G Koliakos, A G P Konstas, U Schlotzer-Schrehardt, G Hollo, D Mitova, D Kovatchev, S Maloutas, and N Georgiadis Endothelin-1 concentration is increased in the aqueous humour of patients with exfoliation syndrome Br. J. Ophthalmol., April 1, 2004; 88(4): 523 - 527. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
